JP
Joseph Pantginis HC Wainwright & Co. Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Travere Therapeutics
TVTX
$1.89B
| $21.15 | $47 |
122%
upside
| Buy | yesterday |
|
2 |
2
Lexicon Pharmaceuticals
LXRX
$389M
| $1.07 | $4 |
274%
upside
| Buy | 2 days ago |
|
3 |
3
Ligand Pharmaceuticals
LGND
$3.27B
| $167.74 | $206 |
23%
upside
| Buy | 7 days ago |
|
4 |
4
Krystal Biotech
KRYS
$4.33B
| $149.75 | $240 |
60%
upside
| Buy | 13 days ago |
|
5 |
5
Celldex Therapeutics
CLDX
$1.51B
| $22.78 | $42 |
84%
upside
| Buy | 15 days ago |
|
6 |
6
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $102 |
284%
upside
| Buy | 16 days ago |
|
7 |
7
Iovance Biotherapeutics
IOVA
$796M
| $2.20 | $20 |
809%
upside
| Buy | 16 days ago |
|
8 |
8
Astria Therapeutics
ATXS
$395M
| $7 | $16 |
129%
upside
| Buy | 22 days ago |
|
9 |
9
Capricor Therapeutics
CAPR
$272M
| $5.94 | $24 |
304%
upside
| Buy | 1 month ago |
|
10 |
10
Edgewise Therapeutics
EWTX
$1.54B
| $14.62 | $42 |
187%
upside
| Buy | 2 months ago |
|
11 |
11
Cidara Therapeutics
CDTX
$1.65B
| $64.93 | $53 |
18%
downside
| Buy | 2 months ago |
|
12 |
12
Lineage Cell Therapeutics
LCTX
$274M
| $1.20 | $9 |
650%
upside
| Buy | 2 months ago |
|
13 |
13
Esperion Therapeutics
ESPR
$510M
| $2.53 | $16 |
532%
upside
| Buy | 2 months ago |
|
14 |
14
Galectin Therapeutics
GALT
$299M
| $4.67 | $6 |
28%
upside
| Buy | 2 months ago |
|
15 |
ATYR
15
aTyr Pharma
ATYR
$536M
| $5.47 | $35 |
540%
upside
| Buy | 3 months ago |
|
16 |
16
Xoma
XOMA
$428M
| $35.40 | $104 |
194%
upside
| Buy | 3 months ago |
|
17 |
17
Kura Oncology
KURA
$706M
| $8.13 | $40 |
392%
upside
| Buy | 4 months ago |
|
18 |
18
Compass Therapeutics
CMPX
$466M
| $3.37 | $24 |
612%
upside
| Buy | 4 months ago |
|
19 |
19
Cytokinetics
CYTK
$5.95B
| $49.75 | $120 |
141%
upside
| Buy | 4 months ago |
|
20 |
PHAR
20
Pharming Group
PHAR
$1.02B
| $14.87 | $37 |
149%
upside
| Buy | 5 months ago |
|
21 |
21
Rigel Pharmaceuticals
RIGL
$720M
| $40.13 | $57 |
42%
upside
| Buy | 6 months ago |
|